HEVA Researchers Detail New Studies and Findings in the Area of HIV/AIDS (Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database): Immune System Diseases and Conditions – HIV/AIDS
2021 DEC 15 (NewsRx) -- By a
The news correspondents obtained a quote from the research from HEVA: “All PLWHIV present in the database in 2013 were identified. All healthcare resource consumption from 2008 to 2015 inclusive was documented and costed (for 2013 to 2015) from the perspective of public health insurance. High-cost and high mortality patient profiles were identified by a machine learning algorithm. In 2013, 96,423 PLWHIV were identified in the SNDS database, including 3,373 incident cases. Overall, 3,224 PLWHIV died during the three-year follow-up period (mean annual mortality rate: 1.1%). The mean annual per capita cost incurred by PLWHIV was € 14,223, corresponding to a total management cost of HIV of € 1,370 million in 2013. The largest contribution came from the cost of antiretroviral medication (M€ 870; 63%) followed by hospitalisation (M€ 154; 11%). The costs incurred in the year preceding death were considerably higher. Four specific patient profiles were identified for under/over-expressing these costs, suggesting ways to reduce them.”
According to the news reporters, the research concluded: “Even though current therapeutic regimens provide excellent virological control in most patients, PLWHIV have excess mortality. Other factors such as comorbidities, lifestyle factors and screening for cancer and cardiovascular disease, need to be targeted in order to lower the mortality and cost associated with HIV infection.”
For more information on this research see: Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database.
A free version of this journal article is available at https://doi.org/10.4081/jphr.2021.2601.
Our news editors report that more information may be obtained by contacting Martin Prodel, HEVA,
(Our reports deliver fact-based news of research and discoveries from around the world.)
The Hartford Declares Quarterly Dividend Of $375 Per Share Of Series G Preferred Stock
Health Spending Soared 10% In 2020 Even Though People Got Less Care. Here’s Why
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News